Huda Y. Zoghbi is Director at REGENERON PHARMACEUTICALS, INC. (REGN). They have made 6 open-market trades across 1 company since 2020, most recently 2026-08-10.
CIK 0001681643
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| REGN | 1,703 | $1.3M |
Shares reported on the most recent Form 4, priced at the 2026-08-12 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| REGN | SELL · 10b5-1 | 2026-08-10 | 2026-08-12 | $800.00 | $640K | +4.0% | -2.0% | — |
| REGN | SELL | 2026-02-19 | 2026-02-23 | $781.33 | $1.3M | -2.0% | -4.0% | -18.7% |
| REGN | SELL · 10b5-1 | 2024-01-02 | 2024-01-04 | $900.00 | $1.0M | +2.7% | +3.5% | +5.1% |
| REGN | SELL · 10b5-1 | 2023-10-13 | 2023-10-17 | $850.00 | $850K | -7.0% | -4.4% | +12.5% |
| REGN | SELL | 2022-03-16 | 2022-03-18 | $675.00 | $1.4M | +0.7% | +5.2% | -19.0% |
| REGN | SELL | 2021-09-13 | 2021-09-15 | $650.00 | $650K | -4.7% | -14.8% | +3.3% |
| REGN | SELL | 2020-07-07 | 2020-07-08 | $650.00 | $1.1M | +1.6% | -4.3% | -10.2% |
| REGN | SELL | 2020-06-10 | 2020-06-12 | $615.16 | $3.1M | +3.5% | +5.4% | -5.9% |
| REGN | SELL | 2020-05-07 | 2020-05-08 | $566.52 | $5.8M | +2.1% | +6.9% | +9.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.